The Quantellect read.As of Nov 19, 2026, 3 active firms cover DarioHealth Corp: 2 rate it Buy or better, 1 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $8.00 to $12.00, a moderate spread. The average target of $10.00 sits 604% above the current $1.42. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.29 next quarter toward $-1.03 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 active firms
Buy
Strong Buy00%
Buy267%
Neutral133%
Sell00%
Strong Sell00%
Based on 3 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$10.00
+604.2% upside
Average target across 3 active firms as of Nov 19, 2026 vs $1.42 current
Highest Target$12.00
Average Target$10.00
Lowest Target$8.00
Detailed analyst forecasts for DRIO
Showing 1–3 of 3 named analysts shown · 3 active firms in the rating projection
As of Nov 19, 2026, 2 of 3 active firms rate DRIO a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
DRIO EPS & revenue forecast
EPS · NEXT QUARTER
$-0.29
Range $-0.29 – $-0.29 · 1 analysts · -70% YoY
Next period, 1 analysts expect DarioHealth Corp to earn $-0.29 a share (range $-0.29 – $-0.29), versus $-0.95 a year earlier. Full-year consensus is $-2.46, growing to $-1.03 the year after.
REVENUE · NEXT QUARTER
$5.9M
Range $5.7M – $6.1M · 1 analysts · +6% YoY
Revenue is expected to reach $5.9M (range $5.7M – $6.1M), +5.9% year-over-year. Full-year consensus is $21.5M, rising to $28.5M next year.
Top analysts covering DarioHealth Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DRIO.
#1
David Grossman
Stifel
Buy
$10.00+604.2% to target
Coverage
—
+ Follow
#2
Charles Rhyee
TD Cowen
Neutral
$8.00+463.4% to target
Coverage
—
+ Follow
#3
SH
Scott Henry
Alliance Global Partners
Buy
$12.00+745.1% to target
Coverage
—
+ Follow
#4
TO
Theodore O'Neill
Litchfield Hills
Buy
$3.00+111.3% to target
Coverage
—
+ Follow
DRIO stock forecast FAQ
What is DRIO's average 12-month price target?+
The 3 active firms with a live target average $10.00 for DarioHealth Corp over the next 12 months, ranging from a $12.00 high to a $8.00 low, as of Nov 19, 2026.
Is DRIO stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 3 active firms as of Nov 19, 2026, 2 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for DRIO?+
The Street-high target is $12.00 (Alliance Global Partners), and the Street-low is $8.00 (TD Cowen). The average of all 3 active-firm targets is $10.00.
How many active Wall Street firms cover DRIO?+
3 active firms have a recognized rating on DarioHealth Corp as of Nov 19, 2026, and 3 active firms carry a live 12-month price target.
Who is the most accurate analyst covering DRIO?+
Among analysts who currently cover DRIO, David Grossman of Stifel has the strongest overall Quantellect track record. Their current call is Buy with a $10.00 target.
What is DarioHealth Corp's projected EPS for next quarter?+
The consensus estimate is $-0.29 per share (range $-0.29 – $-0.29) across 1 analysts. Full-year EPS is projected at $-2.46, rising to $-1.03 the following year.
How much revenue is DarioHealth Corp expected to report next quarter?+
Consensus revenue is $5.9M (range $5.7M – $6.1M). Full-year revenue is projected at $21.5M, growing to $28.5M next year.
Have analysts been upgrading or downgrading DRIO lately?+
As of Nov 19, 2026, 2 of 3 active firms rate DRIO a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DRIO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.